Hormonal Profile and Oxidative Stress are Directed by Anthropometric Measures in Polycystic Ovary syndrome
DOI:
https://doi.org/10.36320/ajb/v7.i3.8072Keywords:
Oxidative Stress , biosynthesisAbstract
We aimed to investigate the relationships between Polycystic Ovary Syndrome (PCOS) and, Hormonal profile and oxidative stress status in patients with polycystic ovary syndrome.Downloads
References
Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet; 370(9588): 685-97(2007). DOI: https://doi.org/10.1016/S0140-6736(07)61345-2
Kuçu NK, Var A. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome. Acta Obstet Gynecol Scand; 88(5): 612-7(2009). DOI: https://doi.org/10.1080/00016340902859315
Agarwal A, Gupta S, Sharma R. Oxidative stress and its implications in female infertility - a clinician's perspective. Reprod Biomed Online; 11(5): 641-50(2005). DOI: https://doi.org/10.1016/S1472-6483(10)61174-1
Sabuncu T, Vural H, Harma M, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem; 34(5): 407-13(2001).
Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab; 50(1): 113-6(1980). DOI: https://doi.org/10.1210/jcem-50-1-113
Legro RS, Kunsel man AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J Clin Endocrinol Metab; 84(1):165-9(1999). DOI: https://doi.org/10.1210/jc.84.1.165
Dahlgren E, Johansson S, Lindstedt G, et al. Women with polycystic
ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones. Fertil Steril; 57(3): 505-13(1992). DOI: https://doi.org/10.1016/S0015-0282(16)54892-4
Khan KA, Stas S, Kurukulasuriya LR. Polycystic ovarian syndrome. J Cardiometab Syndr; 1(2): 125,30; quiz 131-2(2006). DOI: https://doi.org/10.1111/j.1559-4564.2006.05675.x
Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) 1986; 293(6543): 355-9. DOI: https://doi.org/10.1136/bmj.293.6543.355
Azziz R, Carmina E, Dewailly D, et al., Positions statement: Criteria for defining polycystic Ovary syndrome as a predominantly hyperandrogenic Syndrome: an Androgen Excess Society guideline. J Clin. Endocrinol Metab, 91 (11) 4237-4245 Nov. (2004). DOI: https://doi.org/10.1210/jc.2006-0178
Lipa G, Sengupta A, Karsies D. PCOS and other androgen excess-related conditions: can changes in dietary intake make a difference?. Nutr Clin Pract, 23 (1), 63-71 (2008). DOI: https://doi.org/10.1177/011542650802300163
March W, Moure V, Willson K, Phillips D, et al., The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod, 25 (2), 544-551 (2010). DOI: https://doi.org/10.1093/humrep/dep399
Glintborg D, Anderson M, An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecol Endocrinol, 26 (4), 281-296 (2010). DOI: https://doi.org/10.3109/09513590903247873
Blank SK, McCartney CR, Marshall JC, The origins and squeal of abnormal neuroendocrine function in polycystic ovary syndrome. Hum Reprod , 12 (4), 351-361 (2006). DOI: https://doi.org/10.1093/humupd/dml017
Yildiz B, Azziz R, The adrenal and polycystic ovary syndrome. Rev Endocr Metab Disord, 8 (4), 331-342 (2007). DOI: https://doi.org/10.1007/s11154-007-9054-0
Diamenti-Kandarakis E, Argyrakopoulou G, Economou F, Kandaraki E, Koutsilieris M, Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS). J Steroid Biochem Mol Biol, 109 (3-5), 242-246 (2008). DOI: https://doi.org/10.1016/j.jsbmb.2008.03.014
Greiner M, Paredes A, Araya V, Lara HE, Role of stress and sympathetic innervation in the development of polycystic ovary syndrome. Endocrine, 28 (3), 319-324 (2005). DOI: https://doi.org/10.1385/ENDO:28:3:319
Hoeger K. Role of lifestyle modification in the management of polycystic ovary syndrome. Best Practice and Rsch Endo. And Metab Vol. 20, No.2, pp. 293-310(2006). DOI: https://doi.org/10.1016/j.beem.2006.03.008
Korhonen S, Hippelainen M, Vanhala M, Heinonen S, Niskanen L. The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study. Fertil Steril. Jun;79:1327-34(2003). DOI: https://doi.org/10.1016/S0015-0282(03)00347-9
Cussons AJ, Watts GF, Burke V, Shaw JE, Zimmet PZ, Stuckey BG. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Hum Reprod.;23:2352-8 Oct (2008). DOI: https://doi.org/10.1093/humrep/den263
Cupisti S, Dittrich R, Binder H. Influence of BMI on measured and calculated androgen parameters in adult women with Hirsutism and PCOS. Exp Clin Endocrinol Diabetes.;115:380-6 Jun(2007). DOI: https://doi.org/10.1055/s-2007-970163
Zhou G, Myers R, Li Y, Chen Y, et al., Role of A Mp- activated protein kinase in mechanism of metformin action. J Clin Invest, 108: 1167-1174 (2001). DOI: https://doi.org/10.1172/JCI13505
Method for determination of glycosycated chemoglobin. Text book of clinical chemistry McGro Hill.
Sabuncu T, Vural H, Harma M, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem; 34(5): 407-1(2001). DOI: https://doi.org/10.1016/S0009-9120(01)00245-4
Hoeeger, Kristen D, Lynda K, Tracy C, et al., The Impact of Metformin, Oral Contraceptive, and lifestyle Modefication on Polycystic Ovary Syndrome in Obese Adolescent Women in two Randomized, Placebo- Controlled Clinical Trials. J Clin Endocrinol Metabo, 93:4299-4306 (2008). DOI: https://doi.org/10.1210/jc.2008-0461
Velazquez E, Winocour P, Kesteven P, Alberti K and laker M. Relation of lipid peroxides to macrovasclar disease in type 2 diabetes. Diabet Med 8: 752-758(1991). DOI: https://doi.org/10.1111/j.1464-5491.1991.tb01695.x
Zulian E, Sartorato P, Benedini S, Baro G, Armanini D, Mantero F, Scaroni C. Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile. J Endocrinol Invest.,28:49-55(2005). DOI: https://doi.org/10.1007/BF03345529
Guilherme A, Virbasius J, gech M, Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol. Cell Biol ,9 (77): 367-373 May (2008). DOI: https://doi.org/10.1038/nrm2391
Baillargeon J, Nestler J, Polycystic Ovary Syndrome: A syndrome of Ovarian Hyper sensitivity to Insulin?.J Clin Endocrinol Metabo,91:22-24 (2006). DOI: https://doi.org/10.1210/jc.2005-1804
Dinger Y, et al., Glucose sensing in pancreatic beta-cells. A model for the study of other glucose regulated cells in gut, Pancrease, and hypothalamus. Diabetes, 50:1-13 (2002).
Moret M, Stettler R, Rodieux F, Gaillard RC, et al., Insulin modulation of luteinizing hormone secretion in normal female volunteers and lean polycystic ovary syndrome patients. Neuroendocrinology,89:131‐139 (2009). DOI: https://doi.org/10.1159/000160911
Carmina E, Bucchieri S, Esposito A, Del Puente A, et al., Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab,92:2500‐2505(2007). DOI: https://doi.org/10.1210/jc.2006-2725
Bialey C, & Turner R, Metformin, N Engl. J Med.,334: 574-579 (1996) DOI: https://doi.org/10.1056/NEJM199602293340906
Bell PM & Hadden D, Metaformin, Endorinol Metabol Clin N Am,26:523-537 (1997). DOI: https://doi.org/10.1016/S0889-8529(05)70265-6
Dunn C,& Peters D, Metformin: A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs ,49:721-749(1995). DOI: https://doi.org/10.2165/00003495-199549050-00007
Cinti S, Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res, 46:2347-2355(2005). DOI: https://doi.org/10.1194/jlr.M500294-JLR200
Schinner S, Scherbaum W, Bornstein S, and Barthel A, Molecular mechanisms of insulin resistance. Diabet Med, 22(6):674-682(2005). DOI: https://doi.org/10.1111/j.1464-5491.2005.01566.x
Parks E, Krauss R, Christiansen M, Neese R, and Hellerstein M, Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J Clin Invest, 104(8):1087-1096(1999). DOI: https://doi.org/10.1172/JCI6572
Wang J, Obici S, Morgan K, Barzilai N, Feng Z, and Rossetti L, Overfeeding rapidly induces leptin and insulin resistance. Diabetes, 50 (12): 2786-2791(2001). DOI: https://doi.org/10.2337/diabetes.50.12.2786
Shapiro A, et al., Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol, 295 (5): 1370-1375(2008). DOI: https://doi.org/10.1152/ajpregu.00195.2008
Unger R and Scherer P. Gluttony, Sloth and the metabolic syndrome: a roadmap to lipotoxicity. End Met, 21 (6): 345-352(2010). DOI: https://doi.org/10.1016/j.tem.2010.01.009
Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, and Mingrone G, Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest ,100: 1166-1173(1997). DOI: https://doi.org/10.1172/JCI119628
Piroli G, Grillo C, Reznikov L, Adams S, et al., Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus. Neuroendocrinol,85 (2): 71-77(2007). DOI: https://doi.org/10.1159/000101694
Chiu K, Chu A, Go V and Saad M, Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr, 79 (5): 5-820-826(2004). DOI: https://doi.org/10.1093/ajcn/79.5.820
Castagne V, Rougemont M, Cuenod M, and Kim Q, Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat’s development induce long-term cognitive deficit: relevance to schizophrenia. Neurobio Disease, (15): 93-105(2004). DOI: https://doi.org/10.1016/j.nbd.2003.09.005
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Hanaa A.Ali, Majid K. Hussain, Oda M. Yasser
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
